NCT07275879 Evaluation of Quality of Life in Patients After Placement of a Modified Double J Ureteral Stent
| NCT ID | NCT07275879 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Luke's Clinical Hospital, Russia |
| Condition | Ureteral Double-J Stent |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-12-28 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-12-28 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Double-J (DJ) stents are commonly inserted after ureteroscopy. There are several complications associated with the presence of DJ stent: urinary tract infection, stent encrustation, stent migration, and stent-related symptoms (SRS). SRS occur in up to 80% of patients and include pain, hematuria, and dysuria, all of which negatively impact the patient's quality of life. Physicians proposed the distal end of the ureteral stents might involve in SRS by over-simulating the trigone of bladder. The design of the distal end, made with a thinner loop than that of a standard DJ stent, is intended to mitigate SRS and reduce urine reflux.
Eligibility Criteria
Inclusion Criteria: * Patients aged 18 years and older * Patients with kidney stones * Patients with ureteral stones Exclusion Criteria: * Congenital anomalies of the urinary tract * Urinary tract infections * Upper urinary tract obstruction * Complicated ureteroscopy (e.g., ureteral perforation) * Pregnancy * Pre-stented patients
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07275879 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Ureteral Double-J Stent. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07275879 currently recruiting?
Yes, NCT07275879 is actively recruiting participants. Contact the research team at doc.dmitriysytnik@gmail.com for enrollment information.
Where is the NCT07275879 trial being conducted?
This trial is being conducted at Saint Petersburg, Russia.
Who is sponsoring the NCT07275879 clinical trial?
NCT07275879 is sponsored by St. Luke's Clinical Hospital, Russia. The trial plans to enroll 40 participants.